Motion sickness

Indication for Cinnarizine

Population group: Suitable for both men and women, only adolescents (12 years - 18 years old) , adults (18 years old or older)

Cinnarizine is also effective in the control of motion sickness.

For this indication, competent medicine agencies globally authorize below treatments:

30 mg

Route of admnistration

Oral

Defined daily dose

30 - 30 mg

Dosage regimen

From 30 To 30 mg once every day

Detailed description

Adults, elderly and children over 12 years: 30 mg 2 hours before you travel and 15 mg every 8 hours during your journey.

Dosage considerations

Cinnarizine should preferably be taken after meals.

Active ingredient

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

Read more about Cinnarizine

Related medicines

Summary of Product Characteristics (SPC) 2018: STUGERON Tablet

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner